Search results
Aug 30, 2023 · CONSHOHOCKEN, Pa. (August 30, 2023) – Cencora, Inc. (NYSE: COR) today announced the completion of its name and stock ticker change from AmerisourceBergen Corporation (NYSE: ABC), marking the latest stage of the company’s evolution as a leader in global pharmaceutical services.
Cencora is a pharmaceutical solutions organization improving the lives of people and animals. Discover how we empower patient-centered care.
Cencora enables our customers to bring their aspirations, innovations, and essential services to patients around the world. Wherever your business fits in the healthcare continuum, we have industry-leading solutions that accelerate better outcomes from concept to delivery.
We’re advancing pharmaceutical care as Cencora. In August 2023, we united all the companies and services of AmerisourceBergen in our common purpose to create healthier futures. We’re now accelerating positive outcomes for our customers and their patients under our new name, Cencora. Learn more about who we are.
Over our 150 years, we’ve continued to invest in our core pharmaceutical distribution business while expanding our pharma and biopharma services. We're continuing to build solutions, products, and technologies that will reshape how we deliver healthcare. Explore our history.
Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world....
At Cencora, delivering solutions that help change patients' lives for the better is just the beginning of how we make a difference in the world. We're also committed to advancing our environmental, social, and governance (ESG) initiatives to create healthier futures.
